Display options
Share it on

Exp Ther Med. 2015 May;9(5):1979-1983. doi: 10.3892/etm.2015.2310. Epub 2015 Feb 24.

Effect of osteopontin on the mRNA expression of ADAMTS4 and ADAMTS5 in chondrocytes from patients with knee osteoarthritis.

Experimental and therapeutic medicine

Shu-Guang Gao, Chao Zeng, Yang Song, Jian Tian, Chao Cheng, Tuo Yang, Hui Li, Fang-Jie Zhang, Guang-Hua Lei

Affiliations

  1. Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China ; Orthopedics Institute, Central South University, Changsha, Hunan 410008, P.R. China.
  2. Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
  3. Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China ; Department of Orthopedics, Linyi People's Hospital, Linyi, Shandong 276001, P.R. China.

PMID: 26136925 PMCID: PMC4471803 DOI: 10.3892/etm.2015.2310

Abstract

Previous studies have demonstrated that osteopontin (OPN) levels are elevated in the synovial fluid and articular cartilage, and are associated with the severity of knee osteoarthritis (OA). However, the role of OPN in the pathogenesis of OA has yet to be elucidated. The present study aimed to investigate the effects of OPN on the expression of the aggrecanases, a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)4 and ADAMTS5, in human OA chondrocytes, as they serve a key function in aggrecan degradation. Human OA chondrocytes were obtained from the knees of 16 patients with OA, and subsequently cultured in a monolayer. The chondrocytes were divided into three groups, which included the control (no treatment), N-OPN (treated with 100 ng/ml OPN, the normal circulating OPN concentration) and the H-OPN groups (treated with 1 µg/ml OPN, a high OPN concentration). Reverse transcription-quantitative polymerase chain reaction was performed to quantify the relative mRNA expression levels of ADAMTS4, ADAMTS5 and aggrecan in the chondrocytes. The mRNA expression levels of ADAMTS4 were significantly reduced in the N-OPN and H-OPN groups when compared with the control group (P<0.0001). In addition, the mRNA expression levels of ADAMTS4 were lower in the H-OPN group when compared with the N-OPN group (P<0.001). However, no statistically significant difference was observed in the relative mRNA expression levels of ADAMTS5 among the three groups (P>0.05). Furthermore, the mRNA expression levels of aggrecan were higher in the N-OPN and H-OPN groups when compared with the control group (P<0.0001), and a statistically significant difference was observed between the N-OPN and H-OPN groups with regard to the mRNA expression of aggrecan (P<0.0001). These results demonstrated that OPN may exert a protective effect in human OA chondrocytes against aggrecan degradation by suppressing the expression of ADAMTS4.

Keywords: a disintegrin and metalloproteinase with thrombospondin motifs 4; a disintegrin and metalloproteinase with thrombospondin motifs 5; aggrecan; osteoarthritis; osteopontin

References

  1. Matrix Biol. 2000 Jul;19(3):245-55 - PubMed
  2. Expert Opin Drug Metab Toxicol. 2007 Aug;3(4):519-26 - PubMed
  3. Osteoarthritis Cartilage. 2010 Jan;18(1):82-7 - PubMed
  4. Osteoarthritis Cartilage. 2013 Jan;21(1):144-50 - PubMed
  5. Oncogene. 2010 Apr 1;29(13):1941-51 - PubMed
  6. J Am Acad Dermatol. 2009 Feb;60(2):225-30 - PubMed
  7. J Biol Chem. 2006 Aug 25;281(34):24381-9 - PubMed
  8. Osteoarthritis Cartilage. 2010 Jun;18(6):839-48 - PubMed
  9. Arthritis Rheum. 2001 Mar;44(3):578-84 - PubMed
  10. Osteoarthritis Cartilage. 2001 Aug;9(6):539-52 - PubMed
  11. Rheumatol Int. 2009 Mar;29(5):525-34 - PubMed
  12. J Rheumatol. 2002 Oct;29(10):2061-7 - PubMed
  13. Ann Rheum Dis. 2004 Dec;63(12):1618-22 - PubMed
  14. Nature. 2005 Mar 31;434(7033):648-52 - PubMed
  15. Ann Rheum Dis. 2005 Nov;64(11):1624-32 - PubMed
  16. Arthritis Rheum. 2009 Aug;60(8):2362-71 - PubMed
  17. Lancet. 2011 Jun 18;377(9783):2115-26 - PubMed
  18. J Exp Med. 2008 Jan 21;205(1):25-33 - PubMed
  19. Arthritis Rheum. 2012 Jan;64(1):187-97 - PubMed
  20. Arthritis Rheum. 2000 Jul;43(7):1597-605 - PubMed
  21. J Cell Biochem. 2011 Dec;112(12 ):3507-14 - PubMed
  22. Arthritis Rheum. 1986 Aug;29(8):1039-49 - PubMed
  23. Ann Rheum Dis. 2009 Jun;68(6):1051-8 - PubMed
  24. Arthritis Rheum. 2002 Apr;46(4):961-7 - PubMed
  25. Exp Oncol. 2004 Sep;26(3):179-84 - PubMed
  26. J Clin Invest. 2005 Apr;115(4):1060-7 - PubMed
  27. Arthritis Rheum. 2009 Oct;60(10):2902-12 - PubMed
  28. Osteoporos Int. 2011 Aug;22(8):2261-71 - PubMed
  29. Annu Rev Pharmacol Toxicol. 2001;41:723-49 - PubMed
  30. Nature. 2005 Mar 31;434(7033):644-8 - PubMed
  31. Rheumatol Int. 2012 May;32(5):1189-95 - PubMed
  32. Arthritis Res Ther. 2010;12 (6):R230 - PubMed
  33. Osteoarthritis Cartilage. 2004 Apr;12 (4):296-305 - PubMed
  34. Mol Biol Rep. 2010 Mar;37(3):1241-5 - PubMed
  35. J Orthop Sci. 2010 Sep;15(5):666-73 - PubMed
  36. Pathol Int. 2007 Nov;57(11):703-11 - PubMed

Publication Types